| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |